Jerome B Zeldis Ptc Therapeutics, Inc. (PTCT) insider trading activity

PTCT Quotes by TradingView

Jerome B Zeldis is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 14,500 shares of PTCT, which is worth approximately $537,950. The most recent transaction as insider was on May 22, 2024, when has been sold 20,000 shares (Common Stock) at a price of $38.24 per share, resulting in proceeds of $764,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.5K
0% 3M change
38.1% 12M change
Total Value Held $537,950

JEROME B ZELDIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2024
SELL
Open market or private sale
$764,800 $38.24 p/Share
20,000 Reduced 57.97%
14,500 Common Stock
May 22 2024
BUY
Exercise of conversion of derivative security
$528,400 $26.42 p/Share
20,000 Added 36.7%
34,500 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 21.62%
14,500 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
4,000 Added 27.59%
10,500 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
3,200 Added 32.99%
6,500 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
1,650 Added 33.33%
3,300 Common Stock

Also insider at

NEXI
NexImmune, Inc. Healthcare
Executive VP of Research & Dev
NXGL
NEXGEL, INC. Healthcare
Director
SNGX
SOLIGENIX, INC. Healthcare
JBZ

Jerome B Zeldis

South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTCT